EffRx Seeks New Business Collaborations at the BIO International Convention Digital 2021

EffRx-Newsroom-News-20210609

News EffRx Seeks New Business Collaborations at the BIO International Convention Digital 2021 June 9, 2021 EffRx Seeks New Business Collaborations at the BIO International Convention Digital 2021 At the BIO International Convention Digital, taking place June 10-11 & 14-18, 2021, EffRx pro-actively seeks in-licensing opportunities for Europe in niche therapeutic areas, with a primary […]

Dr. Nathalie Véron Appointed Director Technical Operations & Qualified Person at EffRx Pharmaceuticals

EffRx-Newsroom-News-20210525

News Dr. Nathalie Véron Appointed Director Technical Operations & Qualified Person at EffRx Pharmaceuticals May 25, 2021 Dr. Nathalie Véron Appointed Director Technical Operations & Qualified Person at EffRx Pharmaceuticals FREIENBACH, Switzerland – EffRx Pharmaceuticals SA is pleased to announce the appointment of Dr. Nathalie Véron as Director Technical Operations & Qualified Person. She is […]

EffRx Pharmaceuticals Announces the Release of Binosto® Data in Two Publications

EffRx-Newsroom-News-20210215

News EffRx Pharmaceuticals Announces the Release of Binosto® Data in Two Publications February 15, 2021 EffRx Pharmaceuticals Announces the Release of Binosto® Data in Two Publications FREIENBACH, Switzerland – EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced the publication of new scientific data on its […]

EffRx Pharmaceuticals Signs Exclusive License Agreement with Dipharma SA and Launches Miglustat Dipharma in Switzerland

EffRx-Newsroom-News-20201118

News EffRx Pharmaceuticals Signs Exclusive License Agreement with Dipharma SA and Launches Miglustat Dipharma in Switzerland November 18, 2020 EEffRx Pharmaceuticals Signs Exclusive License Agreement with Dipharma SA and Launches Miglustat Dipharma in Switzerland FREIENBACH, Switzerland – EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced […]

EffRx Mourns Passing of Board Member Anders Wiklund

EffRx-Newsroom-News-20200819

News EffRx Mourns Passing of Board Member Anders Wiklund August 19, 2020 EffRx Mourns Passing of Board Member Anders Wiklund FREIENBACH, Switzerland, 19th August 2020. The leadership of EffRx Pharmaceuticals SA is extremely saddened to announce the passing of longtime Board Member and former Chairman, Anders P. Wiklund. Anders, a Swedish citizen, has been a board […]

World Osteoporosis Day – WOD marked on October 20th: THAT’S OSTEOPOROSIS

EffRx-Newsroom-News-20200818

News World Osteoporosis Day – WOD marked on October 20th: THAT’S OSTEOPOROSIS August 19, 2020 World Osteoporosis Day – WOD marked on October 20th: THAT’S OSTEOPOROSIS Countdown to World Osteoporosis Day:A digital countdown checklist is an easy way to learn good bone health basics. Get Started Now! WOD, marked on October 20 each year, is […]

COVID-19 and Osteoporosis

EffRx-Newsroom-News-20200325

News COVID-19 and Osteoporosis March 25, 2020 COVID-19 and Osteoporosis Stay safe and well informed. The IOF provides some helpful information for older adults and people with osteoporosis. Contact Wolleraustrasse 41B, 8807 Freienbach, Switzerland +41 44 503 78 60 info@effrx.com SHARE THIS ARTICLE

EffRx Pharmaceuticals Statement on COVID-19

EffRx-Newsroom-News-20200323

News EffRx Pharmaceuticals Statement on COVID-19 March 23, 2020 EffRx Pharmaceuticals Statement on COVID-19 The globe has literally gone into quarantine due to the COVID-19 outbreak. This is an unprecedented crisis situation in terms of breadth and scale, from a global health, social and economic standpoint. While committed to keep our core activities unaffected, EffRx […]

EffRx Pharmaceuticals Attending the 38th Annual J.P. Morgan Healthcare Conference from January 13-16, 2020 in San Francisco

EffRx-Newsroom-News-20200108

News EffRx Pharmaceuticals Attending the 38th Annual J.P. Morgan Healthcare Conference from January 13-16, 2020 in San Francisco January 8, 2020 EffRx Pharmaceuticals Attending the 38th Annual J.P. Morgan Healthcare Conference from January 13-16, 2020 in San Francisco The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the […]